Listed

Xeriant, Inc.: Form 10-K for the period ended Jun 30, 2025

Filed with the SEC on Oct 2, 2025 and accepted by EDGAR at Oct 2, 2025, 16:44 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2024-07-01 to 2025-06-30$69.3kus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2024-07-01 to 2025-06-30−$1.4mus-gaap:OperatingIncomeLoss
Interest expense12 months2024-07-01 to 2025-06-30$225.6kus-gaap:InterestExpense
Income tax12 months2024-07-01 to 2025-06-30$0us-gaap:IncomeTaxExpenseBenefit
Net income12 months2024-07-01 to 2025-06-30−$1.6mus-gaap:NetIncomeLoss
Diluted EPS12 months2024-07-01 to 2025-06-30$0.00us-gaap:EarningsPerShareDiluted
Diluted shares (weighted)12 months2024-07-01 to 2025-06-30620,875,226 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2024-07-01 to 2025-06-30−$1.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2024-07-01 to 2025-06-30$1.8kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Current assetsAt period end2025-06-30$56.7kus-gaap:AssetsCurrent
Total assetsAt period end2025-06-30$68.2kus-gaap:Assets
Current liabilitiesAt period end2025-06-30$8.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-06-30$8.8mus-gaap:Liabilities
Shareholders' equityAt period end2025-06-30−$5.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001477932-25-007303. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.